Leading dulaglutide claim?

Do you mean the main FDA-approved indication (the official claim) or the typical marketing tagline used in ads?

If you want the official, labeled claim:
- Dulaglutide is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. It is a once-weekly injectable GLP-1 receptor agonist.
- Efficacy claims in trials include lowering HbA1c and, in many patients, weight reduction. The REWIND cardiovascular outcomes trial also showed a reduction in major adverse cardiovascular events in adults with type 2 diabetes.

If you’re asking about marketing language:
- Advertisements often emphasize its once-weekly dosing and the convenience of not needing daily injections, plus the goal of better blood sugar control (and often weight loss as a secondary benefit).

If you want the exact current wording for a specific region (US vs EU), tell me which region and I can provide the precise phrasing from the label or marketing materials.